{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:33:46Z","timestamp":1793126026328,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaclp.2026.06.009","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:25:58Z","timestamp":1783121158000},"page":"409-442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular Effects of Droperidol: A Clinically-Focused Review for the Consultation-Liaison and Emergency Psychiatrist"],"prefix":"10.1016","volume":"67","author":[{"given":"Mirza","family":"Baig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-6782","authenticated-orcid":false,"given":"Matthew","family":"Gunther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-2851","authenticated-orcid":false,"given":"Christopher M.","family":"Celano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra E.","family":"Morfin Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7093-9959","authenticated-orcid":false,"given":"Caitlin","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery C.","family":"Huffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-1798","authenticated-orcid":false,"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7513-9515","authenticated-orcid":false,"given":"Scott R.","family":"Beach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaclp.2026.06.009_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0736-4679(03)00044-1","article-title":"Droperidol in the emergency department: is it safe?","volume":"24","author":"Richards","year":"2003","journal-title":"J Emerg Med"},{"issue":"suppl 5","key":"10.1016\/j.jaclp.2026.06.009_bib3","first-page":"1","article-title":"Practice guideline for the treatment of patients with delirium","volume":"156","year":"1999","journal-title":"Am J Psych"},{"key":"10.1016\/j.jaclp.2026.06.009_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1553-2712.2002.tb02301.x","article-title":"Droperidol--behind the black box warning","volume":"9","author":"Horowitz","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib5","first-page":"3","article-title":"The effects of the FDA warning on the use of droperidol by U.S. emergency physicians","volume":"4","author":"Richards","year":"2003","journal-title":"Cal J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib6","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ajem.2013.03.026","article-title":"Parenteral sedation of elderly patients with acute behavioral disturbance in the ED","volume":"31","author":"Calver","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.annemergmed.2015.03.016","article-title":"The safety and effectiveness of droperidol for sedation of acute behavioral disturbance in the emergency department","volume":"66","author":"Calver","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jemermed.2022.12.012","article-title":"Droperidol use in the emergency department: a clinical review","volume":"64","author":"Siegel","year":"2023","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib9","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1213\/ane.0b013e3181693844","article-title":"FDA response to droperidol black box warning editorials","volume":"106","author":"Rappaport","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaclp.2026.06.009_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jemermed.2014.12.024","article-title":"American academy of emergency medicine position statement: safety of droperidol use in the emergency department","volume":"49","author":"Perkins","year":"2015","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.annemergmed.2023.09.010","article-title":"Clinical policy: critical issues in the evaluation and management of adult out-of-hospital or emergency department patients presenting with severe agitation: approved by the ACEP board of directors, October 6, 2023","volume":"83","author":"Thiessen","year":"2024","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.auec.2020.08.004","article-title":"Safety and effectiveness of olanzapine and droperidol for chemical restraint for non-consenting adults: a systematic review and meta-analysis","volume":"24","author":"Muir-Cochrane","year":"2021","journal-title":"Australas Emerg Care"},{"key":"10.1016\/j.jaclp.2026.06.009_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.annemergmed.2017.05.005","article-title":"What is the efficacy of droperidol for the management of acute psychosis-induced agitation?","volume":"71","author":"Gottlieb","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib14","article-title":"Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis","volume":"10","author":"Weibel","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaclp.2026.06.009_bib15","article-title":"Droperidol for psychosis-induced aggression or agitation","volume":"12","author":"Khokhar","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaclp.2026.06.009_bib16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00540-013-1625-5","article-title":"The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction","volume":"27","author":"Toyoda","year":"2013","journal-title":"J Anesth"},{"key":"10.1016\/j.jaclp.2026.06.009_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2012.07.118","article-title":"Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"61","author":"Chan","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/ALN.0b013e31817fd8c8","article-title":"Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study","volume":"109","author":"Charbit","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaclp.2026.06.009_bib19","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1213\/ane.0b013e3181609424","article-title":"The prophylactic effect of haloperidol plus dexamethasone on postoperative nausea and vomiting in patients undergoing laparoscopically assisted vaginal hysterectomy","volume":"106","author":"Chu","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaclp.2026.06.009_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1590\/S0034-70942008000100005","article-title":"Prophylactic antiemetic therapy for acute abdominal surgery. A comparative study of droperidol, metoclopramide, tropisetron, granisetron and dexamethasone","volume":"58","author":"Contreras-Dom\u00ednguez","year":"2008","journal-title":"Rev Bras Anestesiol"},{"key":"10.1016\/j.jaclp.2026.06.009_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1399-6576.2007.01525.x","article-title":"Low-dose haloperidol prevents post-operative nausea and vomiting after ambulatory laparoscopic surgery","volume":"52","author":"Wang","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jaclp.2026.06.009_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1213\/01.ane.0000252929.88517.b0","article-title":"The antipruritic and antiemetic effects of epidural droperidol: a study of three methods of administration","volume":"105","author":"Lee","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaclp.2026.06.009_bib23","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1213\/01.ane.0000239223.74552.0a","article-title":"The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting","volume":"103","author":"Chan","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaclp.2026.06.009_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S0265021505002218","article-title":"Antipruritic and antiemetic effect of epidural droperidol: comparative study between single and continuous epidural injection","volume":"23","author":"Lee","year":"2006","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jaclp.2026.06.009_bib25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00000542-200506000-00007","article-title":"Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study","volume":"102","author":"White","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaclp.2026.06.009_bib26","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ophtha.2004.01.031","article-title":"Droperidol and dolasetron alone or in combination for prevention of postoperative nausea and vomiting after vitrectomy","volume":"111","author":"Eberhart","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaclp.2026.06.009_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.redar.2015.01.017","article-title":"Effects of droperidol and ondansetron on dispersion of ventricular repolarization: a randomized double-blind clinical study in anesthetized adult patients","volume":"62","author":"Ag\u00e1mez Medina","year":"2015","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"10.1016\/j.jaclp.2026.06.009_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1192\/bjp.bp.114.150227","article-title":"Droperidol v. haloperidol for sedation of aggressive behaviour in acute mental health: randomised controlled trial","volume":"206","author":"Calver","year":"2015","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jaclp.2026.06.009_bib29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/bcp.12527","article-title":"Small doses of droperidol do not present relevant torsadogenic actions: a double-blind, ondansetron-controlled study","volume":"79","author":"Tracz","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaclp.2026.06.009_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.annemergmed.2010.05.037","article-title":"Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study","volume":"56","author":"Isbister","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annemergmed.2005.07.003","article-title":"Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department","volume":"47","author":"Knott","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib32","first-page":"298","article-title":"Droperidol vs. haloperidol in the initial management of acutely agitated patients","volume":"45","author":"Resnick","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaclp.2026.06.009_bib33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1213\/00000539-199411000-00028","article-title":"Droperidol causes a dose-dependent prolongation of the QT interval","volume":"79","author":"Lischke","year":"1994","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaclp.2026.06.009_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/2050312118813283","article-title":"The pharmacokinetics of intranasal droperidol in volunteers characterised via population modelling","volume":"6","author":"Cooper","year":"2018","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib35","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","article-title":"Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron","volume":"102","author":"Charbit","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaclp.2026.06.009_bib36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12873-024-01158-9","article-title":"Evaluation of droperidol use in the emergency department: a retrospective analysis of QTc prolongation and adverse events","volume":"24","author":"Alshehri","year":"2024","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/JCP.0000000000001688","article-title":"A study of cardiac outcomes after droperidol administration in an inpatient psychiatric cohort","volume":"43","author":"Yang","year":"2023","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jaclp.2026.06.009_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ajem.2021.12.039","article-title":"Prospective real-time evaluation of the QTc interval variation after low-dose droperidol among emergency department patients","volume":"52","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib39","doi-asserted-by":"crossref","first-page":"728","DOI":"10.5811\/westjem.2020.4.47036","article-title":"The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department","volume":"21","author":"Cole","year":"2020","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib40","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ajem.2019.09.007","article-title":"Effectiveness and safety of droperidol in a United States emergency department","volume":"38","author":"Gaw","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib41","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bcp.12272","article-title":"High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings","volume":"77","author":"Calver","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaclp.2026.06.009_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/10903127.2013.864353","article-title":"Comparison of droperidol and haloperidol for use by paramedics: assessment of safety and effectiveness","volume":"18","author":"Macht","year":"2014","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jaclp.2026.06.009_bib43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.anes.0000281893.39781.64","article-title":"Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?","volume":"107","author":"Nuttall","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaclp.2026.06.009_bib44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.gie.2006.01.052","article-title":"Droperidol, when used for sedation during ERCP, may prolong the QT interval","volume":"63","author":"Yimcharoen","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaclp.2026.06.009_bib45","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaclp.2026.06.009_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajem.2024.12.082","article-title":"DRopEridol for abdominal pain in the emergency department for Morphine equivalent reduction. The DREAMER study","volume":"90","author":"Townsend","year":"2025","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/acem.13486","article-title":"Parenteral antipsychotic choice and its association with emergency department length of stay for acute agitation secondary to alcohol intoxication","volume":"26","author":"Cole","year":"2019","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib48","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jemermed.2018.12.036","article-title":"Rescue sedation when treating acute agitation in the emergency department with intramuscular antipsychotics","volume":"56","author":"Klein","year":"2019","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/ALN.0b013e31827dde8d","article-title":"Does low-dose droperidol increase the risk of polymorphic ventricular tachycardia or death in the surgical patient?","volume":"118","author":"Nuttall","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaclp.2026.06.009_bib50","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ajem.2011.08.010","article-title":"Treating primary headaches in the ED: can droperidol regain its role?","volume":"30","author":"Faine","year":"2012","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib51","first-page":"1402","article-title":"A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population","volume":"9","author":"Chase","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajem.2023.03.058","article-title":"Retrospective evaluation of ketamine versus droperidol on time to restraint removal in agitated emergency department patients","volume":"69","author":"Krenz","year":"2023","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03006779","article-title":"Cardiovascular effects of droperiodol during enflurane and enfluarne-nitrous oxide anaethesia in man","volume":"25","author":"Stanley","year":"1978","journal-title":"Can Anaesth Soc J"},{"key":"10.1016\/j.jaclp.2026.06.009_bib54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2044.1987.tb04047.x","article-title":"Postoperative complications of dystrophia myotonica","volume":"42","author":"Moore","year":"1987","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jaclp.2026.06.009_bib55","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1213\/01.ane.0000246585.94075.i91","article-title":"Coronary artery spasm as a cause of droperidol-induced ventricular fibrillation","volume":"103","author":"Miyai","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaclp.2026.06.009_bib56","first-page":"822","article-title":"Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance","volume":"90","author":"Faigel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaclp.2026.06.009_bib57","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1345\/aph.17351","article-title":"Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction","volume":"32","author":"Michalets","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaclp.2026.06.009_bib58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/10903120802706096","article-title":"Torsade de Pointes after administration of droperidol for nausea and vomiting","volume":"13","author":"Choo","year":"2009","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jaclp.2026.06.009_bib59","article-title":"Delayed ventricular tachycardia after prophylactic doses of droperidol in patients with mild QT interval prolongation due to preoperative medication","volume":"13","author":"Takechi","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jaclp.2026.06.009_bib60","first-page":"21","article-title":"Association between droperidol use and sudden death in two patients intoxicated with illicit stimulant drugs","volume":"46","author":"Cox","year":"2004","journal-title":"Vet Hum Toxicol"},{"key":"10.1016\/j.jaclp.2026.06.009_bib61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5811\/westjem.2011.9.6866","article-title":"The psychopharmacology of agitation: consensus statement of the American association for emergency psychiatry project beta psychopharmacology workgroup","volume":"13","author":"Wilson","year":"2012","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0196-0644(05)82660-5","article-title":"Droperidol versus haloperidol for chemical restraint of agitated and combative patients","volume":"21","author":"Thomas","year":"1992","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib63","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003088-199937060-00001","article-title":"Pharmacokinetics of haloperidol: an update","volume":"37","author":"Kudo","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaclp.2026.06.009_bib64","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1592\/phco.28.7.875","article-title":"Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration: a pilot pharmacokinetic study","volume":"28","author":"Miller","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaclp.2026.06.009_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine. Pharmacokinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaclp.2026.06.009_bib67","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2146\/ajhp060505","article-title":"Evidence-based review of the black-box warning for droperidol","volume":"64","author":"Jackson","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaclp.2026.06.009_bib68","series-title":"The Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs [ICH Guideline, Step 5] [Internet]","year":"2005"},{"key":"10.1016\/j.jaclp.2026.06.009_bib69","series-title":"E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs [Guidance for Industry] [Internet]","year":"2005"},{"key":"10.1016\/j.jaclp.2026.06.009_bib70","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.genhosppsych.2020.08.008","article-title":"Intravenous haloperidol: a systematic review of side effects and recommendations for clinical use","volume":"67","author":"Beach","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jaclp.2026.06.009_bib71","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaclp.2026.06.009_bib72","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.euroneuro.2014.12.005","article-title":"Cardiac effects of sertindole and quetiapine: analysis of ECGs from a randomized double-blind study in patients with schizophrenia","volume":"25","author":"Nielsen","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jaclp.2026.06.009_bib73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.jcp.0000104913.75206.62","article-title":"A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition","volume":"24","author":"Harrigan","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jaclp.2026.06.009_bib74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JCP.0b013e31827c0314","article-title":"A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and\/or CYP3A4 and a comparison to quetiapine and ziprasidone","volume":"33","author":"Potkin","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jaclp.2026.06.009_bib75","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00002018-199411060-00007","article-title":"Drug-induced torsade de pointes. Incidence, management and prevention","volume":"11","author":"Faber","year":"1994","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaclp.2026.06.009_bib76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psym.2017.10.009","article-title":"QT Prolongation, Torsades de Pointes, and Psychotropic Medications: a 5-year update","volume":"59","author":"Beach","year":"2018","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jaclp.2026.06.009_bib77","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.52034","article-title":"Antipsychotics and the QTc interval during delirium in the intensive care unit: a secondary analysis of a randomized clinical trial","volume":"7","author":"Stollings","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaclp.2026.06.009_bib78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/HRP.0000000000000456","article-title":"Intravenous haloperidol, agitation, and the QTc: misconceptions and heuristics","volume":"34","author":"Levinsohn","year":"2026","journal-title":"Harv Rev Psychiatry"},{"key":"10.1016\/j.jaclp.2026.06.009_bib79","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psym.2017.10.009","article-title":"QT Prolongation, Torsades de Pointes, and Psychotropic Medications: a 5-Year Update","volume":"59","author":"Beach","year":"2018","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jaclp.2026.06.009_bib80","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/08850666231222470","article-title":"Risk stratification of QTc prolongation in critically ill patients receiving antipsychotics for the management of delirium symptoms","volume":"40","author":"Sadlonova","year":"2025","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib81","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2010.01.001","article-title":"Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"55","author":"Drew","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaclp.2026.06.009_bib82","first-page":"348","article-title":"Developing clinical guidelines","volume":"170","author":"Shekelle","year":"1999","journal-title":"West J Med"},{"key":"10.1016\/j.jaclp.2026.06.009_bib83","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/02698811231158232","article-title":"Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology","volume":"37","author":"Rogers","year":"2023","journal-title":"J Psychopharmacol"}],"container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296026000716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296026000716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:51:36Z","timestamp":1793123496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667296026000716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2667296026000716"],"URL":"https:\/\/doi.org\/10.1016\/j.jaclp.2026.06.009","relation":{},"ISSN":["2667-2960"],"issn-type":[{"value":"2667-2960","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Effects of Droperidol: A Clinically-Focused Review for the Consultation-Liaison and Emergency Psychiatrist","name":"articletitle","label":"Article Title"},{"value":"Journal of the Academy of Consultation-Liaison Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaclp.2026.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}